Necrobiosis lipoidica

Specialty
Dermatology · Metabolic skin disorders
Images
Clinical 2 · Histology 1
In the app
5 flashcards
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (3)
  2. Definition
  3. Clinical features
  4. Diagnosis
  5. Differential diagnoses
  6. Treatment principles
  7. Keep learning in the app
  8. References (selection)
  9. Cross-references

Images (3)

Necrobiosis lipoidica – leg – clinical photo: extensive, partly ulcerated yellow-brown plaque with a garland-shaped border on the shin in diabetes
extensive, partly ulcerated yellow-brown plaque with a garland-shaped border on the shin in diabetesWarfieldian, “Necrobiosislipoidica”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
Necrobiosis lipoidica – histology (H&E, low power): layered, 'tiered' palisading granulomas alternating with necrobiotic collagen throughout the dermisHistology
histology (H&E, low power): layered, 'tiered' palisading granulomas alternating with necrobiotic collagen throughout the dermisNephron, “Necrobiosis lipoidica - low mag”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
Necrobiosis lipoidica – leg – clinical photo: yellowish, atrophic plaque with a reddish-violet rim on the shin of a diabetic patient
yellowish, atrophic plaque with a reddish-violet rim on the shin of a diabetic patientడా. గన్నవరపు నరసింహమూర్తి, CC0 · CC0 · Source
1 / 3

Definition

Definition & Pathogenesis

  • Necrobiosis lipoidica (NL, formerly Necrobiosis lipoidica diabeticorum) = idiopathic / diabetes-associated granulomatous dermatosis with collagen degeneration + lipid deposition.
  • Pathogenesis: Suspected mechanisms are microangiopathy + immune complex vasculitis + disturbed collagen metabolism + increased TGF-β / adhesion molecule expression + Th1-driven granuloma formation.
  • Diabetes association: Correct regarding the association NL ↔ diabetes is approx. 11–65 % of NL patients have diabetes (type 1 > type 2), but only < 0.3–1 % of diabetics develop NL — diabetes control does NOT correlate with course of skin lesions.
  • Associated diseases: thyroid autoimmunity, inflammatory bowel diseases, rheumatoid arthritis, sarcoidosis comorbidity discussed.

Clinical features

Clinical Presentation

  • Location: Predilection is pretibial bilateral (> 85 %), less often thigh, forearm, hands, scalp.
  • Morphology: Classic efflorescence is sharply demarcated, yellowish-orange atrophic plaques with livid-erythematous border + visible telangiectasias ("waxy" atrophy).
  • Ulceration: Ulceration risk is approx. 25–35 % in course, often painful, poorly healing, banal-trauma-associated.
  • Symptoms: long asymptomatic, later pain / hypoesthesia (nerve fiber destruction in plaque), pruritus possible.
  • Course: chronic progressive, spontaneous remission rare (< 20 %).

Diagnosis

Diagnostics

  • Clinical usually diagnostic (typical yellowish-atrophic pretibial plaques).
  • Histology: Pathognomonic are palisading granulomas around necrobiosis zones (degenerated collagen bundles) throughout the entire dermis, "horizontally layered/tiered", plasma cell involvement, possibly lipid deposits.
  • Laboratory: fasting blood glucose / oGTT / HbA1c (diabetes screening), thyroid parameters, possibly ANA / RF / ACE.
  • In ulceration: biopsy of border → SCC exclusion (rarely squamous cell carcinoma on chronic NL).

Differential diagnoses

Image credits for the thumbnails
  • Granuloma annulare: Kreuter et al., “Generalized granuloma annulare”, CC BY-SA 2.0, via Wikimedia Commons · CC BY-SA 2.0 · Source
  • Diabetic dermopathy (shin spots): Abate, Aroucha, Nóbrega et al. (2025), “Cutaneous manifestations of diabetes mellitus: a narrative review”, CC BY 4.0, via Wikimedia Commons · CC BY 4.0 · Source
  • Morphea: Leith C Jones at English Wikipedia, “MercMorphea”, CC BY 3.0, via Wikimedia Commons · CC BY 3.0 · Source
  • Limited systemic sclerosis (CREST syndrome): James Heilman, MD, “CREST syndrome (calcinosis and sclerodactyly)”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
  • Cutaneous sarcoidosis: Nowack et al., “Cutaneous findings in systemic sarcoidosis”, CC BY-SA 2.0, via Wikimedia Commons · CC BY-SA 2.0 · Source
  • Erythema ab igne: James Heilman, MD, “Hotbottlerash”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
  • Venous leg ulcer: Abdullah Sarhan, “Chronisch-venöse Insuffizienz Stadium (III)”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source

Treatment principles

  • General measures include avoiding minor trauma, smoking cessation and good diabetes control, although this does not correlate with the course of the skin disease.
  • First-line treatment is potent topical glucocorticoids under occlusion or intralesionally at the active border, and topical calcineurin inhibitors; phototherapy (e.g. PUVA) is an adjunct.
  • Refractory disease requires systemic therapies; ulcerated lesions need structured wound management and, if necessary, skin grafting.

Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.

Keep learning in the app

In the DermaFuchs app you can learn Necrobiosis lipoidica with flashcards, exam questions and spot-the-diagnosis – free, in your browser or as an app.

Test yourself: Spot-diagnosis quiz with real cases →

In the app: 5 flashcards

Open in browser  Download on the App Store

References (selection)

  1. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the DermaFuchs app – free, in your browser or as an app.

Related pages: Granuloma annulare · Diabetic dermopathy (shin spots) · Morphea

Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.